Disruption of the Y-Box Binding Protein-1 Results in Suppression of the Epidermal Growth Factor Receptor and HER-2
2006 · Cancer Research · 156 citations
https://doi.org/10.1158/0008-5472.can-05-3561
H
Helen Jiang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
24
Papers
451
Citations
6
h-index
4
i10-index
Helen Jiang is an academic researcher. The author has contributed to research in topics: HER2/EGFR in Cancer Research & Blood transfusion and management & Erythropoietin and Anemia Treatment. The author has an h-index of 6, co-authored 21 publications.
ORCID: 0000-0003-3125-0689Papers by this author
worksEpidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapy
2007 · Breast Cancer Research · 145 citations
https://doi.org/10.1186/bcr1767
Correction: Mesenchymal stem cells transplantation for perianal fistulas: a systematic review and meta-analysis of clinical trials
2024 · Stem Cell Research & Therapy · 0 citations
https://doi.org/10.1186/s13287-024-03664-w
Towards curing type 1 diabetes: Prospects and challenges of allogeneic or xenogeneic donor islet cell transplantation
2025 · World Journal of Transplantation · 0 citations
https://doi.org/10.5500/wjt.v15.i4.101926
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat